| http://dbpedia.org/ontology/abstract
|
ベラリプリド(Veralipride)は、閉経によるの治療のために用いられる神経弛緩薬である。1979年に初めて使用が認可された。アメリカ合衆国では、未だ認可されていない。 2006年9月には、スペインの市場から撤退した。その結果、欧州委員会は欧州医薬品庁に問題を付託した。2007年7月、欧州医薬品庁は、ベラリプリドの市場からの撤廃を勧告した。
, Veralipride (Agreal, Agradil) is a typical … Veralipride (Agreal, Agradil) is a typical antipsychotic of the benzamide class. It is indicated for the treatment of vasomotor symptoms associated with menopause. It is a D2 receptor antagonist and it induces prolactin secretion without any estrogenic or progestagenic effects. It was first authorised for use in 1979. Veralipride has never gained approval in the United States. In September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA). In July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride. marketing authorisations for veralipride.
, Le véralipride (Agréal, Agradil) est un mé … Le véralipride (Agréal, Agradil) est un médicament neuroleptique de la famille des benzamide indiqué dans le traitement de symptômes vasomoteurs (bouffées de chaleur) associés à la ménopause. Il a d'abord été autorisé pour une utilisation en 1979. Le véralipride n'a jamais obtenu l'approbation aux États-Unis. En septembre 2006, il a été retiré du marché espagnol. En conséquence, la Commission européenne a renvoyé l'affaire à l'Agence européenne des médicaments (EMA). En juillet 2007, l'EMA a recommandé le retrait des autorisations de mise sur le marché de l’ensemble de cette classe de médicament .l’ensemble de cette classe de médicament .
, Veraliprida, também conhecido pela marca A … Veraliprida, também conhecido pela marca Agreal, é um fármaco neuroléptico derivado da benzamida utilizado para alívio da sintomatologia associada à menopausa. Em 2007, a Agência Europeia de Medicamentos (EMA) recomendou à Comissão Europeia que fossem revogadas todas as autorizações de introdução no mercado (AIM) em virtude dos benefícios da utilização do fármaco serem muito pequenos comparados com as suas contraindicações.s comparados com as suas contraindicações.
, La veralipride è un neurolettico che prese … La veralipride è un neurolettico che presenta attività antagonista della dopamina a livello dei recettori D2 e attività antigonadotropica. Il farmaco agirebbe ripristinando l'equilibrio neurotrasmettitoriale ipotalamico responsabile delle manifestazioni cardiovascolari e psichiche che accompagnano la menopausa. Stimola, inoltre, la secrezione di prolattina.ola, inoltre, la secrezione di prolattina.
|
| http://dbpedia.org/ontology/alternativeName
|
Agreal, Agradil
|
| http://dbpedia.org/ontology/casNumber
|
66644-81-3
|
| http://dbpedia.org/ontology/chEBI
|
135600
|
| http://dbpedia.org/ontology/chEMBL
|
2105581
|
| http://dbpedia.org/ontology/fdaUniiCode
|
S7064109UD
|
| http://dbpedia.org/ontology/kegg
|
D07311
|
| http://dbpedia.org/ontology/pubchem
|
47979
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Veralipride.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
16980227
|
| http://dbpedia.org/ontology/wikiPageLength
|
2946
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1093779039
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Vasomotor +
, http://dbpedia.org/resource/Levosulpiride +
, http://dbpedia.org/resource/Prolactin +
, http://dbpedia.org/resource/Category:Benzamides +
, http://dbpedia.org/resource/Benzamide +
, http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Pyrrolidines +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Category:Typical_antipsychotics +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Category:Withdrawn_drugs +
, http://dbpedia.org/resource/Typical_antipsychotic +
, http://dbpedia.org/resource/Dopamine_receptor_D2 +
, http://dbpedia.org/resource/Category:Allyl_compounds +
, http://dbpedia.org/resource/Menopause +
|
| http://dbpedia.org/property/alt
|
Ball-and-stick model of the veralipride molecule
|
| http://dbpedia.org/property/atcPrefix
|
N05
|
| http://dbpedia.org/property/atcSuffix
|
AL06
|
| http://dbpedia.org/property/c
|
17
|
| http://dbpedia.org/property/casNumber
|
66644
|
| http://dbpedia.org/property/chebi
|
135600
|
| http://dbpedia.org/property/chembl
|
2105581
|
| http://dbpedia.org/property/chemspiderid
|
43638
|
| http://dbpedia.org/property/h
|
25
|
| http://dbpedia.org/property/image
|
Veralipride molecule ball.png
|
| http://dbpedia.org/property/iupacName
|
23
|
| http://dbpedia.org/property/kegg
|
D07311
|
| http://dbpedia.org/property/legalStatus
|
Rx-only
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
5
|
| http://dbpedia.org/property/pubchem
|
47979
|
| http://dbpedia.org/property/routesOfAdministration
|
Oral
|
| http://dbpedia.org/property/s
|
1
|
| http://dbpedia.org/property/smiles
|
COC1=CCSN
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
RYJXBGGBZJGVQF-UHFFFAOYSA-N
|
| http://dbpedia.org/property/tradename
|
Agreal, Agradil
|
| http://dbpedia.org/property/unii
|
S7064109UD
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
448091146
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/width
|
240
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Antipsychotics +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Dopaminergics +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Pyrrolidines +
, http://dbpedia.org/resource/Category:Allyl_compounds +
, http://dbpedia.org/resource/Category:Typical_antipsychotics +
, http://dbpedia.org/resource/Category:Benzamides +
, http://dbpedia.org/resource/Category:Withdrawn_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Medicine +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Veralipride?oldid=1093779039&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Veralipride.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Veralipride_molecule_ball.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Veralipride +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q3564216 +
, http://fa.dbpedia.org/resource/%D9%88%D8%B1%D8%A7%D9%84%DB%8C%E2%80%8C%D9%BE%DB%8C%D8%B1%DB%8C%D8%AF +
, https://global.dbpedia.org/id/3HrWW +
, http://ja.dbpedia.org/resource/%E3%83%99%E3%83%A9%E3%83%AA%E3%83%97%E3%83%AA%E3%83%89 +
, http://sr.dbpedia.org/resource/Veraliprid +
, http://dbpedia.org/resource/Veralipride +
, http://fr.dbpedia.org/resource/V%C3%A9ralipride +
, http://sh.dbpedia.org/resource/Veraliprid +
, http://yago-knowledge.org/resource/Veralipride +
, http://it.dbpedia.org/resource/Veralipride +
, http://rdf.freebase.com/ns/m.0414993 +
, http://vi.dbpedia.org/resource/Veralipride +
, http://pt.dbpedia.org/resource/Veraliprida +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatDrugs +
, http://dbpedia.org/class/yago/WikicatSulfonamides +
, http://dbpedia.org/class/yago/SulfaDrug104352070 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/WikicatWithdrawnDrugs +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Antibacterial102716205 +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Substance100020090 +
|
| rdfs:comment |
Veraliprida, também conhecido pela marca A … Veraliprida, também conhecido pela marca Agreal, é um fármaco neuroléptico derivado da benzamida utilizado para alívio da sintomatologia associada à menopausa. Em 2007, a Agência Europeia de Medicamentos (EMA) recomendou à Comissão Europeia que fossem revogadas todas as autorizações de introdução no mercado (AIM) em virtude dos benefícios da utilização do fármaco serem muito pequenos comparados com as suas contraindicações.s comparados com as suas contraindicações.
, ベラリプリド(Veralipride)は、閉経によるの治療のために用いられる神経弛緩薬である。1979年に初めて使用が認可された。アメリカ合衆国では、未だ認可されていない。 2006年9月には、スペインの市場から撤退した。その結果、欧州委員会は欧州医薬品庁に問題を付託した。2007年7月、欧州医薬品庁は、ベラリプリドの市場からの撤廃を勧告した。
, La veralipride è un neurolettico che prese … La veralipride è un neurolettico che presenta attività antagonista della dopamina a livello dei recettori D2 e attività antigonadotropica. Il farmaco agirebbe ripristinando l'equilibrio neurotrasmettitoriale ipotalamico responsabile delle manifestazioni cardiovascolari e psichiche che accompagnano la menopausa. Stimola, inoltre, la secrezione di prolattina.ola, inoltre, la secrezione di prolattina.
, Le véralipride (Agréal, Agradil) est un mé … Le véralipride (Agréal, Agradil) est un médicament neuroleptique de la famille des benzamide indiqué dans le traitement de symptômes vasomoteurs (bouffées de chaleur) associés à la ménopause. Il a d'abord été autorisé pour une utilisation en 1979. Le véralipride n'a jamais obtenu l'approbation aux États-Unis. En septembre 2006, il a été retiré du marché espagnol. En conséquence, la Commission européenne a renvoyé l'affaire à l'Agence européenne des médicaments (EMA).l'Agence européenne des médicaments (EMA).
, Veralipride (Agreal, Agradil) is a typical … Veralipride (Agreal, Agradil) is a typical antipsychotic of the benzamide class. It is indicated for the treatment of vasomotor symptoms associated with menopause. It is a D2 receptor antagonist and it induces prolactin secretion without any estrogenic or progestagenic effects. It was first authorised for use in 1979. Veralipride has never gained approval in the United States.ever gained approval in the United States.
|
| rdfs:label |
ベラリプリド
, Veralipride
, Veraliprida
, Véralipride
|
